This case report highlights the aggressive nature and poor prognosis of angiosarcoma of the breast despite surgical and systemic treatment.
Highlights poor prognosis of breast angiosarcoma despite treatment; case reports leave open need for novel therapies.
A case of angiosarcoma of the breast which is rare and carries the worst prognosis of any breast malig-nancies is presented. A 42-year-old housekeeper was admitted to the hospital because of a painful and elastic hard tumor with ill-defined margin and 5×5cm in diameter in her left breast. Incisional biopsy was per-formed and the tumor was diagnosed as a lymphangioma, so she was discharged. Two years later, she was admitted again with the same symptom as those in two years ago. The tumor size increased to 6×6cm in diameter and a color of the skin over the tumor is changed to dark purple tone. Aspiration biopsy from the tumor revealed class IV. Consequently a modified radical mastectomy and axillary dissection were performed with a suspicion of malignant breast tumor. Pathological findings revealed that the tumor was angiosarcoma of the breast. After the operation multi-disciplinary treatment including systemic administration of interleukin 2 was carried out, but in vain. She experienced metastasis 13 months after the operation and died from tumor metastasis. An autopsy disclosed metastasis to the liver, adrenal gland and bone.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: